Skandinaviska Enskilda Banken (SEB)
ONEM

Skandinaviska Enskilda Banken (SEB)’s 1Life Healthcare ONEM Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,300
Closed -$423K – 951
2022
Q4 		$423K Buy
+25,300
New +$427K ﹤0.01% 741
2022
Q2 		– Sell
-26,247
Closed -$291K – 1091
2022
Q1 		$291K Sell
26,247
-13,255
-34% -$148K ﹤0.01% 868
2021
Q4 		$686K Buy
39,502
+225
+0.6% +$4.36K ﹤0.01% 816
2021
Q3 		$795K Buy
39,277
+2,046
+5% +$52.6K ﹤0.01% 820
2021
Q2 		$1.23M Buy
37,231
+1,072
+3% +$40.5K 0.01% 776
2021
Q1 		$1.41M Buy
36,159
+2,361
+7% +$111K 0.01% 749
2020
Q4 		$1.48M Buy
+33,798
New +$1.15M 0.01% 733

Skandinaviska Enskilda Banken (SEB)'s ONEM Position: Q1 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 25,300 shares — an estimated $423K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ONEM in Q4 2020 and held it in 7 quarters. The position peaked at $1.48M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 25,300 1Life Healthcare shares in Q1 2023, an estimated $423K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in 1Life Healthcare in Q4 2020 and held it in 7 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s 1Life Healthcare position peaked at $1.48M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2023, filed 11 May 2023.